MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

How do people with Parkinson’s disease experience self-optimization of treatment using digitally supported symptom monitoring?

K. Fåglum, A. Hjorth, M. Christani, P. Hagell, A. Ozanne, F. Bergquist (Varberg, Sweden)

Meeting: 2023 International Congress

Abstract Number: 1757

Keywords: Interventions, Parkinson’s, Wearing-off fluctuations

Category: Technology

Objective: The aim of this study was to investigate how people with Parkinson´s disease experience an intervention of optimizing their own medical treatment through digitally supported self-monitoring.

Background: Parkinson’s disease is an incurable, progressive neurodegenerative movement disorder. Treatment is symptomatic. Medication related fluctuations in symptoms need to be treated since this has an impact on everyday life. Digital tools have been used for monitoring symptom fluctuations in an objective way, but with limited access of data to the patients.

We hypothesized that patient driven adjustment of medication guided by the digital monitoring can increase patient empowerment. A digital wrist-worn symptom diary (PSW) which patients can use to self-monitor and evaluate symptoms on a web platform, was used.

Method: A conveniency sample of seven patients, 4 women and 3 men, 33 to 80 years old from two neurology clinics participated. They used the PSW for at least 4 weeks and could change medication within predefined limits guided by the PSW platform and online material about treating symptom fluctuations. To investigate the patient experience of using the intervention, a qualitative semi-structured interview, was performed after 4-6 weeks of PSW use. Inductive content analysis was used to analyze the interviews.

Results: Two categories and five subcategories emerged showing that self-monitoring in combination with optimizing drug therapy through self-management leads to a feeling of increased participation and empowerment that increases the ability to self-care. Social and individual barriers as well as inadequate digital tool design were aggravating factors that constituted barriers to self-care. [figure1]

Conclusion: Self-management through digital self-monitoring can contribute to empowering people with Parkinson’s disease in their self-care. The intervention is a complement that will not replace contact with care, but the possibility of using digital tools to improve self-management of PD with the support of specialist PD nurses should be further explored using devices tailored for this purpose.

Kategorier

To cite this abstract in AMA style:

K. Fåglum, A. Hjorth, M. Christani, P. Hagell, A. Ozanne, F. Bergquist. How do people with Parkinson’s disease experience self-optimization of treatment using digitally supported symptom monitoring? [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/how-do-people-with-parkinsons-disease-experience-self-optimization-of-treatment-using-digitally-supported-symptom-monitoring/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/how-do-people-with-parkinsons-disease-experience-self-optimization-of-treatment-using-digitally-supported-symptom-monitoring/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley